Analyst Price Targets — ARAY
| Date | Analyst | Firm | Target | Price @ Post | Source | Headline |
|---|---|---|---|---|---|---|
| February 5, 2026 12:19 pm | — | BTIG | $2.00 | $0.76 | TheFly | Accuray price target lowered to $2 from $4 at BTIG |
| May 2, 2024 5:24 am | Maria Thibault | BTIG | $6.00 | $2.17 | StreetInsider | Accuray (ARAY) PT Lowered to $6 at BTIG |
| June 24, 2022 9:10 am | — | BTIG | $7.00 | $2.23 | Benzinga | BTIG Maintains Buy on Accuray, Lowers Price Target to $7 |
Latest News for ARAY
MADISON, Wis., May 29, 2026 /PRNewswire/ -- Accuray Incorporated (NASDAQ: ARAY) today reported, as required by NASDAQ Listing Rules, equity inducement awards to Paul Miele, the company's new Chief Commercial Officer and David Shin, the company's new Chief Legal Officer.
MADISON, Wis., May 15, 2026 /PRNewswire/ -- Accuray Incorporated (NASDAQ: ARAY) and the University of Wisconsin School of Medicine and Public Health (UW SMPH) announced a new 10‑year strategic collaboration to advance personalized cancer treatments using Accuray's Stellar™ adaptive radiation therapy platform.
Accuray Incorporated (ARAY) Q3 2026 Earnings Call Transcript
MADISON, Wis., May 6, 2026 /PRNewswire/ -- Accuray Incorporated (NASDAQ: ARAY) today reported financial results for the third quarter ended March 31, 2026.
MADISON, Wis., April 22, 2026 /PRNewswire/ -- Accuray Incorporated (NASDAQ: ARAY) will report financial results for the third quarter of fiscal year 2026, ended March 31, 2026, during a conference call hosted by company management at 1:30 p.m.
🧮 Earnings Move Analyzer
Insider Trading
Insider Trading
| Name | Role | Date | Type | Shares | Price | Form | Link |
|---|
Senate Trading
No Senate trades found for ARAY.
U.S. House Trading
No House trades found for ARAY.
Options Chain
Select an expiration to expand. Bid/Ask are shown first (before Mark) on both sides.